Inhibition of Mitochondrial Respiratory Chain in the Brain of Adult Rats After Acute and Chronic Administration of Methylphenidate

[1]  D. Leblanc-Duchin,et al.  Chronic oral methylphenidate induces post-treatment impairment in recognition and spatial memory in adult rats , 2009, Neurobiology of Learning and Memory.

[2]  J. Quevedo,et al.  Methylphenidate increases creatine kinase activity in the brain of young and adult rats. , 2008, Life sciences.

[3]  A. Tein,et al.  Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells , 2008, Journal of Gastroenterology.

[4]  T. Wilens.  Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder , 2008, Journal of clinical psychopharmacology.

[5]  B. Frey,et al.  DNA damage in rats after treatment with methylphenidate , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  C. Drake,et al.  Methylphenidate Administration to Juvenile Rats Alters Brain Areas Involved in Cognition, Motivated Behaviors, Appetite, and Stress , 2007, The Journal of Neuroscience.

[7]  B. Frey,et al.  Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats , 2007, Behavioural pharmacology.

[8]  N. Sen,et al.  Depolarization and cardiolipin depletion in aged rat brain mitochondria: Relationship with oxidative stress and electron transport chain activity , 2007, Neurochemistry International.

[9]  M. Wilkinson,et al.  Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum , 2007, Neuroscience.

[10]  J. Quevedo,et al.  Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats , 2007, International Journal of Developmental Neuroscience.

[11]  A. Navarro,et al.  The mitochondrial energy transduction system and the aging process. , 2007, American journal of physiology. Cell physiology.

[12]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[13]  H. Steiner,et al.  Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits , 2005, Neuroscience.

[14]  Vera Adam-Vizi,et al.  Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. , 2005, Antioxidants & redox signaling.

[15]  S. Faraone,et al.  Attention-deficit hyperactivity disorder , 2005, The Lancet.

[16]  Yu-Shin Ding,et al.  Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[17]  S. Heales,et al.  Mitochondrial Disease: A Historical, Biochemical, and London Perspective , 2004, Neurochemical Research.

[18]  Joseph Biederman,et al.  The worldwide prevalence of ADHD: is it an American condition? , 2003, World psychiatry : official journal of the World Psychiatric Association.

[19]  V. O. Wagner,et al.  D-Methylphenidate is non-genotoxic in in vitro and in vivo assays. , 2003, Mutation research.

[20]  M. Wilkinson,et al.  Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats , 2003, Neuroreport.

[21]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[22]  D. Segal,et al.  Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine , 2002, The Journal of Neuroscience.

[23]  N. Volkow,et al.  Acute Handling Stress Modulates Methylphenidate-induced Catecholamine Overflow in the Medial Prefrontal Cortex , 2002, Neuropsychopharmacology.

[24]  A. Schurr.  Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia , 2002, Neurochemistry International.

[25]  J. Blass.  Brain metabolism and brain disease: Is metabolic deficiency the proximate cause of Alzheimer dementia? , 2001, Journal of neuroscience research.

[26]  L. K. Baker,et al.  Enhanced Reactivity and Vulnerability to Cocaine Following Methylphenidate Treatment in Adolescent Rats , 2001, Neuropsychopharmacology.

[27]  S. Strakowski,et al.  Human Response to Repeated Low-Dose d-Amphetamine: Evidence for Behavioral Enhancement and Tolerance , 2001, Neuropsychopharmacology.

[28]  G. Page,et al.  Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes , 2001, Journal of neurochemistry.

[29]  D. Segal,et al.  Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. , 2001, The Journal of pharmacology and experimental therapeutics.

[30]  Yu-Shin Ding,et al.  Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain , 2001, The Journal of Neuroscience.

[31]  N. Volkow,et al.  Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor , 2000, Synapse.

[32]  P. Kalivas,et al.  Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies , 2000, Psychopharmacology.

[33]  T. Challman,et al.  Methylphenidate: its pharmacology and uses. , 2000, Mayo Clinic proceedings.

[34]  S. Faraone,et al.  Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. , 2000, The American journal of psychiatry.

[35]  G. Laviola,et al.  Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models , 1999, Neuroscience & Biobehavioral Reviews.

[36]  M. LaVoie,et al.  Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine , 1999, The Journal of Neuroscience.

[37]  J M Land,et al.  Nitric oxide, mitochondria and neurological disease. , 1999, Biochimica et biophysica acta.

[38]  S. Strakowski,et al.  Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans , 1998, Biological Psychiatry.

[39]  S. Strakowski,et al.  Enhanced behavioral response to repeated d-amphetamine and personality traits in humans , 1998, Biological Psychiatry.

[40]  J. Montoya,et al.  Reduced mitochondrial DNA transcription in senescent rat heart. , 1998, Biochemical and biophysical research communications.

[41]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[42]  M. Solanto.  Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration , 1998, Behavioural Brain Research.

[43]  Garland Ej.  Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. , 1998 .

[44]  E. Garland,et al.  Reviews : Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats , 1998, Journal of psychopharmacology.

[45]  G. Barja,et al.  Localization at Complex I and Mechanism of the Higher Free Radical Production of Brain Nonsynaptic Mitochondria in the Short-Lived Rat Than in the Longevous Pigeon , 1998, Journal of bioenergetics and biomembranes.

[46]  R. Klein,et al.  Adult psychiatric status of hyperactive boys grown up. , 1998, The American journal of psychiatry.

[47]  S. Schenk,et al.  Stimulant preexposure sensitizes rats and humans to the rewarding effects of cocaine. , 1998, NIDA research monograph.

[48]  M. Hynes,et al.  Educational and occupational outcome of hyperactive boys grown up. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[49]  M. Solioz,et al.  The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I. , 1997, The Journal of pharmacology and experimental therapeutics.

[50]  D. Segal,et al.  Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with Amphetamine , 1997, Journal of neurochemistry.

[51]  R. Radi,et al.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. , 1996, Archives of biochemistry and biophysics.

[52]  T. Bourgeron,et al.  Biochemical and molecular investigations in respiratory chain deficiencies. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[53]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[54]  D. Safer,et al.  Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children. , 1989, The Journal of pediatrics.

[55]  G. Cohen,et al.  Dopamine turnover and glutathione oxidation: implications for Parkinson disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  G. Lucignani,et al.  Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate relevance to its action in hyperactive children , 1987, Biological Psychiatry.

[57]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[58]  J. Berden,et al.  Differential investigation of the capacity of succinate oxidation in human skeletal muscle. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[59]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[60]  B. Jortner,et al.  Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells , 2009, Neurotoxicity Research.

[61]  L. Greenhill.  Clinical effects of stimulant medication in ADHD. , 2001 .

[62]  F. Castellanos,et al.  Stimulant drugs and ADHD : basic and clinical neuroscience , 2001 .

[63]  Ihab S. Soliman,et al.  Stimulant medications for the treatment of ADHD: Efficacy and limitations , 1999 .